Abstract
Over the past twenty years, the management of F. Hoffman‐La Roche, a Swiss multinational pharmaceutical and chemical producer, has developed a comprehensive process for the analysis of important investment decisions. This process has evolved gradually and naturally, according to management needs and readiness. Today it embodies a full range of decision and risk analysis procedures, which allow rapid but thorough quantitative evaluations of important investment, business development and strategy decisions. The results of this analytical process are routinely presented to top management. In addition, the quantitative evaluation is actively sought out by line managers and functional experts throughout the company.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
